Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) dementia are characterised by progressive brain atrophy. Longitudinal MRI volumetry may help to characterise ongoing structural degeneration and support the differential diagnosis of dementia subtypes. Automated, observer-independent atlas-based MRI volumetry was applied to analyse 102 MRI data sets from 15 bvFTD, 14 AD, and 10 healthy elderly control participants with consecutive scans over at least 12 months. Anatomically defined targets were chosen a priori as brain structures of interest. Groups were compared regarding volumes at clinic presentation and annual change rates. Baseline volumes, especially of grey matter compartments, were significantly reduced in bvFTD and AD patients. Grey matter volumes of the caudate and the gyrus rectus were significantly smaller in bvFTD than AD. The bvFTD group could be separated from AD on the basis of caudate volume with high accuracy (79% cases correct). Annual volume decline was markedly larger in bvFTD and AD than controls, predominantly in white matter of temporal structures. Decline in grey matter volume of the lateral orbitofrontal gyrus separated bvFTD from AD and controls. Automated longitudinal MRI volumetry discriminates bvFTD from AD. In particular, greater reduction of orbitofrontal grey matter and temporal white matter structures after 12 months is indicative of bvFTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, machine learning techniques have been applied to distinguish between bvFTD and Cognitively Normal Subjects (CNCs), Alzheimer Disease or other psychiatric and neurologic disorders on an individual level using MRI-based features. 9-17”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In general, they achieved moderate to high accuracy distinguishing bvFTD.”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Frings et al. showed that annual volume decline was larger in bvFTD, then AD, and then in controls, predominantly in white matter of temporal areas and orbitofrontal grey matter [47].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [47]
In the citing paper
“WM volume, as measured with structural MRI, manifested a steeper decline, especially in the temporal lobe, compared to early GM orbitofrontal and insula atrophy (1 year, N = 15) (Frings et al., 2014).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Frings et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 2×
“Univariate tests were followed by correction of the original p-values according to the method of Benjamini and Hochberg [22] using the MATLAB script available at [www.”
MethodMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · cited 1×
“Modulation compensates for dilatation or shrinkage during spatial normalization and has the effect of preserving the total amount of signal from the respective tissue class in the normalized partitions [21].”
BackgroundSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“The revised diagnostic criteria for bvFTD [6] incorporate neuroimaging evidence of frontal and/or temporal brain atrophy changes at presentation.”
BackgroundSelf-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016 · cited 3×
“All participants from the FRONTIER database underwent general cognitive screening using the Addenbrooke’s Cognitive Examination (ACE-R) [17] to determine their overall cognitive functioning.”
MethodInfluentialSelf-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“Diagnostic criteria for both have been proposed [2,3] but clinical diagnosis remains challenging [4,5].”
BackgroundLongitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain
Resnick, S. M., Pham, D. L., Kraut, M. A., Zonderman, A. B., & Davatzikos, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03295.2003 · Cited by 1,425 · cited 1×
“Annual volume decrease in the group of healthy elderly controls was ,1% overall which is commensurate with prior estimates [36,37].”
ResultThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
The prevalence of frontotemporal dementia
Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,157 · cited 1×
“Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD) are the two most prevalent early-onset dementias [1].”
BackgroundSelf-citation
Cited by
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
“…comparing behavioural variant (bv)FTD, AD and healthy controls with consecutive scans over at least 12 months, Frings et al. showed that annual volume decline was larger in bvFTD, then AD, and then in controls, predominantly in white matter of temporal areas and orbitofrontal grey matter [47].”
BackgroundWhite matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K., Ihara, M., & Kalaria, R. N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 208
“WMH are also common in neurodegenerative dementias including Alzheimer’s disease (AD) (Gouw et al. 2008a; Frings et al. 2014; Prins and Scheltens 2015).”
BackgroundEarly changes in extracellular matrix in Alzheimer's disease
Lepelletier, F. ‐., Mann, D. M. A., Robinson, A. C., Pinteaux, E., & Boutin, H. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12295 · Cited by 198
Huppertz, H., Möller, L., Südmeyer, M., Hilker, R., Hattingen, E., Egger, K., Amtage, F., Respondek, G., Stamelou, M., Schnitzler, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26715 · Cited by 160
“14 15-17 In PSP, it could demonstrate reduced progression of brain atrophy in a randomized, placebo-controlled medication trial.”
BackgroundSelf-citationCohen, R. A., Seider, T. R., & Navia, B. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0123-4 · Cited by 149
“However, cortical changes in AD cases are typically more pronounced than in cases of HIV, and hippocampal atrophy occurs early and ubiquitously in AD whereas the hippocampus is not as vulnerable in HIV [62,63].”
Background
Metadata
- Authors
- Frings, L., Yew, B., Flanagan, E., Lam, B. Y. K., Hüll, M., Huppertz, H.-J., Hodges, J. R., & Hornberger, M.
- Affiliations
- University of Freiburg (DE)
- Neuroscience Research Australia (AU)
- UNSW Sydney (AU)
- Swiss Epilepsy Center (CH)
- Corresponding author
- Hornberger, Michael
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-03
- Volume
- 9
- Issue
- 3
- Pages
- e90814
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3940927
- OpenAlex
- W2034517662
- Cited by
- 69
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 10 · 2018: 9 · 2017: 4 · 2016: 5 · 2015: 6
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Neuroscience Research Australia
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung (01GW0662)
- Medical Research Council
- Australian Research Council (DP110104202, FF0776229)
- National Health and Medical Research Council (FF0776229)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- behavioral variant frontotemporal dementia, Alzheimer's disease, gray matter atrophy, white matter atrophy, caudate nucleus, gyrus rectus, differential diagnosis of dementia, brain atrophy
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Australia, Brain, Diagnosis, Differential, Germany, Humans, Magnetic Resonance Imaging, Organ Size, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0090814
- The paper
- Frings, L., Yew, B., Flanagan, E., Lam, B. Y. K., Hüll, M., Huppertz, H.-J., Hodges, J. R., & Hornberger, M. (2014). Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0090814
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.